Cargando…
IL-17A producing mast cells as therapeutic target in spondyloarthritis
Autores principales: | Yeremenko, N, Gofita, I, Noordenbos, T, Tak, P P, Canete, J, Baeten, D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007787/ http://dx.doi.org/10.1186/1479-5876-8-S1-P42 |
Ejemplares similares
-
IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis
por: Noordenbos, Troy, et al.
Publicado: (2011) -
Identification of robust and disease-specific stromal alterations in spondyloarthritis synovitis
por: Yeremenko, Nataliya, et al.
Publicado: (2011) -
IL-17 in spondyloarthritis: is the T-party over?
por: Yeremenko, Nataliya, et al.
Publicado: (2011) -
Serum biomarkers to predict clinical response in proof-of-concept trials in spondyloarthritis
por: Turina, Maureen, et al.
Publicado: (2011) -
Relative overexpression of membrane-bound versus soluble TNF in spondyloarthritis
por: Ambarus, Carmen A, et al.
Publicado: (2012)